Reuters logo
BRIEF-Cerveau Technologies signs agreement with AbbVie for Novel Tau imaging agent
October 23, 2017 / 8:45 AM / 2 months ago

BRIEF-Cerveau Technologies signs agreement with AbbVie for Novel Tau imaging agent

Oct 23 (Reuters) - Cerveau Technologies Inc:

* Cerveau Technologies Inc signs license and supply agreement with AbbVie for Novel Tau imaging agent

* Announced license and supply agreement with AbbVie for use of MK-6240, an imaging agent to be used in PET scans​ Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below